IRIS Accounts Production v24.3.0.553 14707839 director 6.3.23 31.3.24 31.3.24 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh147078392023-03-05147078392024-03-31147078392023-03-062024-03-31147078392023-03-0514707839ns15:EnglandWales2023-03-062024-03-3114707839ns14:PoundSterling2023-03-062024-03-3114707839ns10:Director12023-03-062024-03-3114707839ns10:PrivateLimitedCompanyLtd2023-03-062024-03-3114707839ns10:Micro-entities2023-03-062024-03-3114707839ns10:AuditExempt-NoAccountantsReport2023-03-062024-03-3114707839ns10:FullAccounts2023-03-062024-03-3114707839ns10:RegisteredOffice2023-03-062024-03-3114707839ns5:CurrentFinancialInstruments2024-03-31
REGISTERED NUMBER: 14707839 (England and Wales)













Unaudited Financial Statements

for the Period 6 March 2023 to 31 March 2024

for

M Mckenna Ophthalmology Limited

M Mckenna Ophthalmology Limited (by shares) (Registered number: 14707839)






Contents of the Financial Statements
for the Period 6 March 2023 to 31 March 2024




Page

Company Information 1

Balance Sheet 2


M Mckenna Ophthalmology Limited (by shares)

Company Information
for the Period 6 March 2023 to 31 March 2024







DIRECTOR: Dr M D C McKenna





REGISTERED OFFICE: 3 Kingfisher Court
Bowesfield Park
Stockton On Tees
United Kingdom
TS18 3EX





REGISTERED NUMBER: 14707839 (England and Wales)





ACCOUNTANTS: Anderson Barrowcliff Limited
Chartered Accountants
3 Kingfisher Court
Bowesfield Park
Stockton on Tees
TS18 3EX

M Mckenna Ophthalmology Limited (by shares) (Registered number: 14707839)

Balance Sheet
31 March 2024

£    £   
FIXED ASSETS 3,024

CURRENT ASSETS 101,546

CREDITORS
Amounts falling due within one year (27,294 )
NET CURRENT ASSETS 74,252
TOTAL ASSETS LESS CURRENT
LIABILITIES

77,276

CAPITAL AND RESERVES 77,276

NOTE TO THE FINANCIAL STATEMENTS

1. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the period was 1 .



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 31 March 2024.

The members have not required the company to obtain an audit of its financial statements for the period ended 31 March 2024 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 2 December 2024 and were signed by:





Dr M D C McKenna - Director